Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental diabetic neuropathy: an update.

A A Sima1, K Sugimoto

  • 1Department of Pathology, Wayne State University, School of Medicine and Detroit Medical Center, Michigan 48201, USA.

Diabetologia
|August 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab).

Journal of the peripheral nervous system : JPNS·2014
Same author

Diabetic neuropathy: pathogenetic background, current and future therapies.

Expert review of neurotherapeutics·2009
Same author

Human C-peptide dose dependently prevents early neuropathy in the BB/Wor-rat.

International journal of experimental diabetes research·2002
Same author

Proinsulin C-peptide--a consensus statement.

International journal of experimental diabetes research·2002
Same author

Has C-peptide come of age?

International journal of experimental diabetes research·2002
Same author

Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. 1994.

Neurology·2002
Same journal

Unhealthy fat distribution as a sex-specific predictor of declining hippocampus insulin sensitivity.

Diabetologia·2026
Same journal

Baseline and longitudinal joint associations of alcohol consumption and obesity with diabetes risk: evaluating multiplicative and additive interactions.

Diabetologia·2026
Same journal

GIP contributes to postprandial regulation of splanchnic blood supply in humans with type 2 diabetes: a randomised, single-blinded, placebo-controlled, crossover study.

Diabetologia·2026
Same journal

Correction: Analysis of glycaemic control with a connected smart pen cap in adults with type 1 diabetes: a randomised, open-label, parallel-group trial.

Diabetologia·2026
Same journal

History of infertility, risk of type 2 diabetes and HbA<sub>1c</sub> levels in the Nurses' Health Study II.

Diabetologia·2026
Same journal

Delayed maturation of the milk microbiome in women with type 1 diabetes.

Diabetologia·2026
See all related articles

Diabetic neuropathy, a common complication of diabetes, involves multiple nerve types. Research highlights distinct differences in diabetic neuropathy between Type I and Type II diabetes, necessitating further study for effective therapies.

Area of Science:

  • Neurology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Diabetic neuropathy encompasses various clinical syndromes affecting motor, sensory, and autonomic nerves.
  • Distal symmetric sensory polyneuropathy is the most prevalent form, commonly termed diabetic neuropathy.
  • Animal models, particularly diabetic rodents, have significantly advanced understanding of diabetic neuropathy pathogenesis.

Purpose of the Study:

  • To elucidate the multifactorial pathogenesis of diabetic neuropathy.
  • To investigate the distinct functional and structural differences in neuropathies associated with Type I and Type II diabetes mellitus.
  • To identify key challenges in understanding the hierarchy of pathogenetic mechanisms for improved therapeutic design.

Main Methods:

  • Review of animal studies, primarily in diabetic rodents.

Related Experiment Videos

  • Analysis of metabolic aberrations implicated in neuropathy.
  • Comparison of neuropathies in Type I and Type II diabetes.

    • Main Results:

    • Diabetic neuropathy pathogenesis is multifactorial, involving interconnected metabolic issues.
    • Key mechanisms include polyol pathway activity, vasoactive substance abnormalities, non-enzymatic glycation, free radical presence, and altered neurotrophism.
    • Distinct differences exist in the expression of neuropathy between Type I and Type II diabetes.

    Conclusions:

    • Understanding the distinct pathogenetic mechanisms and their hierarchy in Type I and Type II diabetic neuropathy is crucial.
    • Current therapies for diabetic neuropathy have shown limited success, underscoring the need for further research.
    • Future research should focus on delineating specific mechanisms for each diabetes type to develop targeted and effective treatments.